{"trigger": ["In vivo modulation of <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma .", ""], "relation": []}
{"trigger": ["BACKGROUND : In vivo regulation of the <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> ( <extra_id_0> GR <extra_id_2> Protein <extra_id_1> ) by glucocorticoids provides a means of modulating sensitivity of targeted cells .", ""], "relation": []}
{"trigger": ["OBJECTIVE : We sought to determine the in vivo modulation of <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA expression by fluticasone propionate ( FP ) in subjects with mild asthma .", ""], "relation": []}
{"trigger": ["METHODS : Ten atopic asthmatic subjects were treated with FP 250 microg twice daily for 4 weeks .", ""], "relation": []}
{"trigger": ["Before and after treatment , the patients underwent fiberoptic bronchoscopy with endobronchial biopsy and sampling of venous blood for measurements of <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA levels .", ""], "relation": []}
{"trigger": ["A solution hybridization assay was used for quantitative analysis of <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA .", ""], "relation": []}
{"trigger": ["In addition , a 24-hour urinary cortisol excretion and an <extra_id_0> adrenocorticotropic hormone <extra_id_2> Protein <extra_id_1> test before and after treatment with FP were performed .", ""], "relation": []}
{"trigger": ["RESULTS : A high interindividual variation in <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA expression was seen .", ""], "relation": []}
{"trigger": ["However , we detected a significant reduction of the <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA levels in the endobronchial biopsy specimens after FP treatment ( 36.6 +/- 23.1 and 25.0 +/- 10.9 amol <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA / microg RNA , respectively ; P < .01 ) .", ""], "relation": []}
{"trigger": ["In the peripheral blood lymphocytes an even more striking downregulation of the <extra_id_0> GR <extra_id_2> Protein <extra_id_1> by its cognate ligand was documented ( 30.3 +/- 26.5 and 8.8 +/- 5 amol <extra_id_0> GR <extra_id_2> Protein <extra_id_1> mRNA / microg RNA , respectively ; P < .001 ) , possibly reflecting differences in glucocorticoid sensitivity between tissues .", ""], "relation": []}
{"trigger": ["A small but significant reduction of the 24-hour urinary cortisol excretion was observed ( 233 +/- 109 and 157 +/- 66 nmol / L , respectively ; P < .01 ) , whereas the feedback regulation of glucocorticoid synthesis by means of the hypothalamic-pituitary-adrenal axis as assessed by the <extra_id_0> adrenocorticotropic hormone <extra_id_2> Protein <extra_id_1> test remained normal after treatment with FP .", ""], "relation": []}
{"trigger": ["CONCLUSION : The results in this study confirm the potency of the inhaled corticosteroid FP and provide evidence for a considerable tissue - specific interindividual variation in the expression of the <extra_id_0> GR <extra_id_2> Protein <extra_id_1> .", ""], "relation": []}
